Preston W. Campbell, President and CEO of the Cystic Fibrosis Foundation to Retire; Michael P. Boyle, MD, Appointed as Successor Effective January 2020

Today the Cystic Fibrosis Foundation announced that President and CEO
Preston W. Campbell, MD, plans to retire at the end of 2019. The
Foundation’s Board of Trustees has selected Michael P. Boyle, MD,
currently Senior Vice President, Therapeutics Development at the CF
Foundation, and former director of the Johns Hopkins Adult Cystic
Fibrosis Program to succeed Dr. Campbell as President and CEO. The two
will work closely together during the transition period preceding Dr.
Boyle’s appointment on Jan. 1, 2020.

This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20190521005806/en/

Michael P. Boyle, MD (Photo: Business Wire)

Dr. Campbell has dedicated his career to expanding opportunities for
people with CF to live longer and healthier lives and fostering hope for
all who are touched by the disease. He has served in a leadership
position at the CF Foundation for more than 20 years, including
President and CEO since 2015. Over the course of his career, the average
life expectancy for a person with CF has increased by more than 15
years, the number of adults has surpassed the number of children with
the disease, and the CF Foundation has enabled the research and
development of multiple therapies to improve the lives of people with CF.

“Preston’s tireless commitment to people with CF has been essential to
the amazing progress we have achieved in the treatment of this disease,”
said Catherine C. McLoud, chair of the CF Foundation Board of Trustees.
“He has played an instrumental role in advancing research and care,
leading with heart while attracting world-class talent to the Foundation
and the field of CF, and investing in programs to support and engage all
people with the disease. As we look to the future, we are confident Mike
will continue to accelerate that progress, furthering transformational
science, care, and programs to meet the needs of people with CF and
their families.”

“It has been an honor to lead the CF Foundation and to stand alongside
people with CF and their families in the relentless pursuit of our
mission, and I believe that now is the right time for a leadership
change,” said Preston W. Campbell, MD. “Today, we are on the cusp of
advances in treatment that are the result of decades of hard work,
collaboration, and commitment by the CF community. The best is yet to
come in CF, and there is no one better prepared to lead the CF
Foundation in achieving our ultimate goal of a cure than Mike Boyle.”

In his current role at the CF Foundation, Dr. Boyle oversees the
clinical development programs of new treatments, as well as the
Foundation's Therapeutic Development Network of 92 academic research
centers. Prior to joining the Foundation, Dr. Boyle served as founding
director of the Johns Hopkins Adult Cystic Fibrosis Program from 1999 to
2015. He is internationally recognized for his clinical research
supporting the development of CFTR modulators and his impact on
improving care for adults with CF.

“Since its inception, the CF Foundation has been a powerful engine of
progress in CF, shaping and powering advances in medical innovation and
care that are helping people with CF to live longer, fuller lives than
ever before,” said Michael P. Boyle, MD. “Still there is much to be done
in our work to support best health for each and every person with CF and
illuminate the path to a cure. I am honored by this opportunity to serve
the CF community and partner with people with CF, their families, and
our outstanding team at the CF Foundation to chart our course for the
future.”

About the Cystic Fibrosis Foundation

The Cystic Fibrosis Foundation is the world’s leader in the search for a
cure for cystic fibrosis. The Foundation funds more CF research than any
other organization, and nearly every CF drug available today was made
possible because of Foundation support. Based in Bethesda, Md., the
Foundation also supports and accredits a national care center network
that has been recognized by the National Institutes of Health as a model
of care for a chronic disease. The CF Foundation is a donor-supported
nonprofit organization. For more information, visit cff.org.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190521005806/en/